Mustang Bio
MBIO
28 hedge funds and large institutions have $373K invested in Mustang Bio in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 8 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
4% more funds holding
Funds holding: 27 → 28 (+1)
0.1% less ownership
Funds ownership: 0.16% → 0.05% (-0.1%)
52% less capital invested
Capital invested by funds: $774K → $373K (-$401K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$73.6K |
| 2 |
KOC
Koss-Olinger Consulting
Gainesville,
Florida
|
+$37.4K |
| 3 |
TFS
Thoroughbred Financial Services
Brentwood,
Tennessee
|
+$20.2K |
| 4 |
Jane Street
New York
|
+$18.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$10K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$218K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$49.5K |
| 3 |
Renaissance Technologies
New York
|
-$37K |
| 4 |
VF
Virtu Financial
New York
|
-$31K |
| 5 |
Squarepoint
New York
|
-$15.5K |
MBIO Hedge Fund Activity: Q2 2024 in Review
28 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q2 2024, worth a combined $373K — down 52% from $774K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new MBIO positions and 8 closed out — a net gain of 1 holder — while 6 added to existing stakes and 5 trimmed.
The largest buyer was UBS Group, adding an estimated $73.6K. The largest seller was Armistice Capital, exiting entirely with an estimated $218K sold.
- 28 institutional investors held Mustang Bio (MBIO) as of Q2 2024, up from 27 in Q1 2024.
- Funds reported $373K of Mustang Bio stock for Q2 2024, down 52% quarter-over-quarter.
- 9 funds opened new Mustang Bio positions in Q2 2024 and 8 closed out, a net change of +1 holder.
- The largest Mustang Bio buyer in Q2 2024 was UBS Group, an estimated $73.6K added.
- The largest Mustang Bio seller in Q2 2024 was Armistice Capital, an estimated $218K sold.
Based on aggregated 13F filings for Q2 2024.